Hugo Calderón

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators

Arthur Dyer, Ying Di, Hugo Calderón et al. · Molecular Therapy — Oncolytics · 2016 · 52 citations · Full text

CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition

Irene Andreu-Saumell, Alba Rodríguez-García, Vanessa Mühlgrabner et al. · Nature Communications · 2024 · 47 citations · Full text

Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes

Nalini Marino, Sam Illingworth, Prithvi Kodialbail et al. · PLoS ONE · 2017 · 30 citations · Full text

Viral Replication, Synthetic Virology, Immunology +16

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

Natalia Egri, Hugo Calderón, Robert Martinez et al. · Frontiers in Immunology · 2023 · 17 citations · Full text

Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction

Luis A. Rojas, Rafael Moreno, Hugo Calderón et al. · Cancer Gene Therapy · 2016 · 13 citations · Full text

Molecular Virology, Systemic Transduction, Viral Pathogenesis +8